Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.

Mendoza N, Ramírez I, de la Viuda E, Coronado P, Baquedano L, Llaneza P, Nieto V, Otero B, Sánchez-Méndez S, de Frutos VÁ, Andraca L, Barriga P, Benítez Z, Bombas T, Cancelo MJ, Cano A, Branco CC, Correa M, Doval JL, Fasero M, Fiol G, Garello NC, Genazzani AR, Gómez AI, Gómez MÁ, González S, Goulis DG, Guinot M, Hernández LR, Herrero S, Iglesias E, Jurado AR, Lete I, Lubián D, Martínez M, Nieto A, Nieto L, Palacios S, Pedreira M, Pérez-Campos E, Plá MJ, Presa J, Quereda F, Ribes M, Romero P, Roca B, Sánchez-Capilla A, Sánchez-Borrego R, Santaballa A, Santamaría A, Simoncini T, Tinahones F, Calaf J

Open source

DOI
10.1016/j.maturitas.2022.08.008
Published
2022 Dec
Container
Maturitas
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.maturitas.2022.08.008,
  title = {Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.},
  author = {Mendoza N and Ramírez I and de la Viuda E and Coronado P and Baquedano L and Llaneza P and Nieto V and Otero B and Sánchez-Méndez S and de Frutos VÁ and Andraca L and Barriga P and Benítez Z and Bombas T and Cancelo MJ and Cano A and Branco CC and Correa M and Doval JL and Fasero M and Fiol G and Garello NC and Genazzani AR and Gómez AI and Gómez MÁ and González S and Goulis DG and Guinot M and Hernández LR and Herrero S and Iglesias E and Jurado AR and Lete I and Lubián D and Martínez M and Nieto A and Nieto L and Palacios S and Pedreira M and Pérez-Campos E and Plá MJ and Presa J and Quereda F and Ribes M and Romero P and Roca B and Sánchez-Capilla A and Sánchez-Borrego R and Santaballa A and Santamaría A and Simoncini T and Tinahones F and Calaf J},
  year = {2022},
  journal = {Maturitas},
  doi = {10.1016/j.maturitas.2022.08.008},
  url = {https://doi.org/10.1016/j.maturitas.2022.08.008}
}

RIS

TY  - JOUR
TI  - Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
AU  - Mendoza N
AU  - Ramírez I
AU  - de la Viuda E
AU  - Coronado P
AU  - Baquedano L
AU  - Llaneza P
AU  - Nieto V
AU  - Otero B
AU  - Sánchez-Méndez S
AU  - de Frutos VÁ
AU  - Andraca L
AU  - Barriga P
AU  - Benítez Z
AU  - Bombas T
AU  - Cancelo MJ
AU  - Cano A
AU  - Branco CC
AU  - Correa M
AU  - Doval JL
AU  - Fasero M
AU  - Fiol G
AU  - Garello NC
AU  - Genazzani AR
AU  - Gómez AI
AU  - Gómez MÁ
AU  - González S
AU  - Goulis DG
AU  - Guinot M
AU  - Hernández LR
AU  - Herrero S
AU  - Iglesias E
AU  - Jurado AR
AU  - Lete I
AU  - Lubián D
AU  - Martínez M
AU  - Nieto A
AU  - Nieto L
AU  - Palacios S
AU  - Pedreira M
AU  - Pérez-Campos E
AU  - Plá MJ
AU  - Presa J
AU  - Quereda F
AU  - Ribes M
AU  - Romero P
AU  - Roca B
AU  - Sánchez-Capilla A
AU  - Sánchez-Borrego R
AU  - Santaballa A
AU  - Santamaría A
AU  - Simoncini T
AU  - Tinahones F
AU  - Calaf J
PY  - 2022
JO  - Maturitas
DO  - 10.1016/j.maturitas.2022.08.008
UR  - https://doi.org/10.1016/j.maturitas.2022.08.008
ER  -

APA

N, M., I, R., E, D. L. V., P, C., L, B., P, L., V, N., B, O., S, S., VÁ, D. F., L, A., P, B., Z, B., T, B., MJ, C., A, C., CC, B., M, C., JL, D., M, F., G, F., NC, G., AR, G., AI, G., MÁ, G., S, G., DG, G., M, G., LR, H., S, H., E, I., AR, J., I, L., D, L., M, M., A, N., L, N., S, P., M, P., E, P., MJ, P., J, P., F, Q., M, R., P, R., B, R., A, S., R, S., A, S., A, S., T, S., F, T., & J, C. (2022). Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.. Maturitas. https://doi.org/10.1016/j.maturitas.2022.08.008

Source records